Pain Management Drugs Global Market Report 2025

Description

A pain management drug is a medication designed to reduce pain, achieving analgesia through actions at multiple levels of the nervous system. These actions include the inhibition of neurotransmitter release from the primary afferent terminals in the spinal cord and the activation of descending inhibitory controls in the midbrain.

The primary classes of pain management drugs comprise non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics. NSAIDs, or nonsteroidal anti-inflammatory drugs, are specifically designed to lower a high fever, reduce inflammation, and alleviate discomfort. They find application in various conditions such as arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, fibromyalgia, muscle sprain/strain, bone fractures, among others. These drugs are distributed through different channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The pain management drugs market research report is one of a series of new reports from The Business Research Company that provides pain management drugs market statistics, including pain management drugs industry global market size, regional shares, competitors with a pain management drugs market share, detailed pain management drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the pain management drugs industry. This pain management drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pain management drugs market size has grown strongly in recent years. It will grow from $80.13 billion in 2024 to $84.51 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising chronic pain cases, rise in cancer cases, increased surgical procedures, improved pain assessment, government initiatives.

The pain management drugs market size is expected to see strong growth in the next few years. It will grow to $106.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to non-opioid alternatives, targeted therapies, precision medicine approaches, psychological interventions, focus on minimizing side effects. Major trends in the forecast period include value-based care models, expanded access programs, combination therapies, innovative formulations, biosimilar pain drugs.

An increasing number of surgeries is anticipated to boost the growth of the pain management drugs market in the future. A surgical procedure involves medical intervention that requires cutting or penetrating the body's tissues to treat diseases, conditions, or injuries, or to alter bodily functions or enhance appearance. Pain management drugs are essential in surgeries as they help control and alleviate post-operative pain, significantly enhancing patient comfort and recovery. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based professional organization for board-certified aesthetic plastic surgeons, released the Global Survey 2022 report, which revealed an 11.2% overall increase in procedures performed by plastic surgeons in 2022, totaling over 14.9 million surgical procedures worldwide. There has been a consistent rise in aesthetic surgery over the past four years, showing a 41.3% increase. Therefore, the rising rate of surgeries is driving the growth of the pain management drugs market.

The growth of the pain management drugs market is further expected to be boosted by the rise in the geriatric population. The geriatric population, comprising individuals aged 65 and older, often requires pain management drugs to alleviate conditions such as arthritis, cancer, and neurological disorders that are more prevalent in later life. According to a report by the World Health Organization (WHO) in October 2022, it is projected that by 2030, one in six individuals globally will be 60 years or older, and the number of individuals over 60 will double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. This demographic shift toward an aging population is a driving force behind the growth of the pain management drugs market.

Technological advancement is a prominent trend gaining traction in the pain management drugs market. Major companies in this sector are concentrating on the development of new technologies. For example, in October 2024, Vertex Pharmaceuticals, a US-based biotechnology firm, announced substantial progress in Suzetrigine (VX-548) for treating acute and neuropathic pain. This innovative medication aims to deliver effective pain relief while minimizing the side effects typically associated with conventional analgesics. The development of Suzetrigine is expected to expand treatment options for patients experiencing various pain conditions, thereby enhancing their quality of life. By advancing this cutting-edge therapy, Vertex seeks to address unmet medical needs in pain management and establish itself as a leader in the pharmaceutical industry.

Major companies in the pain management drugs market are developing drugs and obtaining FDA approval. FDA approval, indicating adherence to safety and efficacy standards, is crucial for commercial distribution in the United States. For instance, in October 2023, Hyloris Pharmaceuticals, a Belgium-based pharmaceutical company, received FDA approval for Maxigesic IV. This non-opioid intravenous painkiller, combining paracetamol and ibuprofen, offers a dual-action mechanism for pain relief and represents a significant advancement in the market, providing a new non-opioid treatment option for post-operative pain relief.

In October 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology firm, acquired Biohaven Pharmaceuticals Inc. for an undisclosed sum. This acquisition is intended to strengthen Pfizer's portfolio in the neurology sector, specifically focusing on the development and commercialization of innovative treatments for neurological disorders. Biohaven Pharmaceuticals Inc. is a US-based biotechnology research company specializing in the development of pain management drugs.

Major companies operating in the pain management drugs market include Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bausch Health Companies Inc., Sanofi, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Daiichi Sankyo Company Limited, Grunenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

North America was the largest region in the pain management drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pain management drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pain management drug market consists of sales of acetaminophen, anti-seizure medications, steroids, muscle relaxers, and other related drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pain Management Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pain management drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pain management drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pain management drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Anesthetics; Anticonvulsants; Anti-Migraine Agents; Antidepressants; Opioids; Nonnarcotic Analgesics
2) By Indication: Arthritic Pain; Neuropathic Pain; Cancer Pain; Chronic Back Pain; Postoperative Pain; Migraine; Fibromyalgia; Muscle Sprain Or Strain; Bone Fracture; Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Aspirin; Diclofenac; Ketorolac
2) By Anesthetics: Local Anesthetics; General Anesthetics
3) By Anticonvulsants: Gabapentin; Pregabalin; Carbamazepine; Topiramate
4) By Anti-Migraine Agents: Triptans; Ergot Alkaloids; CGRP Inhibitors
5) By Antidepressants: Tricyclic Antidepressants; SNRIs
6) By Opioids: Morphine; Oxycodone; Hydrocodone; Fentanyl
7) By Nonnarcotic Analgesics: Acetaminophen; Aspirin; Other Analgesics
Companies Mentioned: Novartis AG; Eli Lilly And Company; Abbott Laboratories; Endo International plc; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23623

1. Executive Summary

2. Pain Management Drugs Market Characteristics

3. Pain Management Drugs Market Trends And Strategies

4. Pain Management Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pain Management Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Pain Management Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pain Management Drugs Market Growth Rate Analysis
5.4. Global Pain Management Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pain Management Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pain Management Drugs Total Addressable Market (TAM)

6. Pain Management Drugs Market Segmentation

6.1. Global Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Anesthetics
Anticonvulsants
Anti-migraine Agents
Antidepressants
Opioids
Nonnarcotic Analgesics
6.2. Global Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Back Pain
Postoperative Pain
Migraine
Fibromyalgia
Muscle sprain/strain
Bone fracture
Other Indications
6.3. Global Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Pain Management Drugs Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ibuprofen
Naproxen
Aspirin
Diclofenac
Ketorolac
6.5. Global Pain Management Drugs Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Local Anesthetics
General Anesthetics
6.6. Global Pain Management Drugs Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gabapentin
Pregabalin
Carbamazepine
Topiramate
6.7. Global Pain Management Drugs Market, Sub-Segmentation Of Anti-Migraine Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Triptans
Ergot Alkaloids
CGRP Inhibitors
6.8. Global Pain Management Drugs Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tricyclic Antidepressants
SNRIs
6.9. Global Pain Management Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Morphine
Oxycodone
Hydrocodone
Fentanyl
6.10. Global Pain Management Drugs Market, Sub-Segmentation Of Nonnarcotic Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acetaminophen
Aspirin
Other Analgesics

7. Pain Management Drugs Market Regional And Country Analysis

7.1. Global Pain Management Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pain Management Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pain Management Drugs Market

8.1. Asia-Pacific Pain Management Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pain Management Drugs Market

9.1. China Pain Management Drugs Market Overview
9.2. China Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pain Management Drugs Market

10.1. India Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pain Management Drugs Market

11.1. Japan Pain Management Drugs Market Overview
11.2. Japan Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pain Management Drugs Market

12.1. Australia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pain Management Drugs Market

13.1. Indonesia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pain Management Drugs Market

14.1. South Korea Pain Management Drugs Market Overview
14.2. South Korea Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pain Management Drugs Market

15.1. Western Europe Pain Management Drugs Market Overview
15.2. Western Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pain Management Drugs Market

16.1. UK Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pain Management Drugs Market

17.1. Germany Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pain Management Drugs Market

18.1. France Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pain Management Drugs Market

19.1. Italy Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pain Management Drugs Market

20.1. Spain Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pain Management Drugs Market

21.1. Eastern Europe Pain Management Drugs Market Overview
21.2. Eastern Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pain Management Drugs Market

22.1. Russia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pain Management Drugs Market

23.1. North America Pain Management Drugs Market Overview
23.2. North America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pain Management Drugs Market

24.1. USA Pain Management Drugs Market Overview
24.2. USA Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pain Management Drugs Market

25.1. Canada Pain Management Drugs Market Overview
25.2. Canada Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pain Management Drugs Market

26.1. South America Pain Management Drugs Market Overview
26.2. South America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pain Management Drugs Market

27.1. Brazil Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pain Management Drugs Market

28.1. Middle East Pain Management Drugs Market Overview
28.2. Middle East Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pain Management Drugs Market

29.1. Africa Pain Management Drugs Market Overview
29.2. Africa Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pain Management Drugs Market Competitive Landscape And Company Profiles

30.1. Pain Management Drugs Market Competitive Landscape
30.2. Pain Management Drugs Market Company Profiles
- 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eli Lilly And Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Endo International plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pain Management Drugs Market Other Major And Innovative Companies

31.1. Merck & Co. Inc.
31.2. Johnson & Johnson Services Inc.
31.3. GlaxoSmithKline plc
31.4. AbbVie Inc.
31.5. Bristol-Myers Squibb Company
31.6. Teva Pharmaceutical Industries Ltd.
31.7. AstraZeneca plc
31.8. Bausch Health Companies Inc.
31.9. Sanofi
31.10. F. Hoffmann-La Roche Ltd.
31.11. Boehringer Ingelheim
31.12. Mallinckrodt Pharmaceuticals
31.13. Daiichi Sankyo Company Limited
31.14. Grunenthal GmbH
31.15. Mundipharma International Limited

32. Global Pain Management Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pain Management Drugs Market

34. Recent Developments In The Pain Management Drugs Market

35. Pain Management Drugs Market High Potential Countries, Segments and Strategies

35.1 Pain Management Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Pain Management Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Pain Management Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer